Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

SELL
$71.24 - $85.35 $5.35 Million - $6.4 Million
-75,031 Reduced 68.64%
34,280 $2.93 Million
Q4 2023

Feb 05, 2024

SELL
$80.59 - $92.61 $26,191 - $30,098
-325 Reduced 0.3%
109,311 $9.35 Million
Q3 2023

Oct 26, 2023

SELL
$82.56 - $93.49 $2.71 Million - $3.07 Million
-32,866 Reduced 23.06%
109,636 $9.82 Million
Q1 2023

May 04, 2023

BUY
$72.75 - $90.6 $209,520 - $260,927
2,880 Added 2.06%
142,502 $11.8 Million
Q4 2022

Feb 03, 2023

SELL
$73.85 - $86.14 $9.37 Million - $10.9 Million
-126,841 Reduced 47.6%
139,622 $11 Million
Q3 2022

Oct 25, 2022

SELL
$63.3 - $78.66 $976,719 - $1.21 Million
-15,430 Reduced 5.47%
266,463 $19.7 Million
Q2 2022

Jul 29, 2022

BUY
$49.27 - $66.08 $2.96 Million - $3.97 Million
60,125 Added 27.11%
281,893 $18.4 Million
Q1 2022

Apr 29, 2022

BUY
$43.77 - $63.22 $9.71 Million - $14 Million
221,768 New
221,768 $14 Million
Q3 2020

Oct 28, 2020

SELL
$75.65 - $93.58 $5.3 Million - $6.55 Million
-70,013 Closed
0 $0
Q2 2020

Jul 28, 2020

SELL
$84.96 - $118.91 $14.1 Million - $19.7 Million
-165,727 Reduced 70.3%
70,013 $6.27 Million
Q1 2020

Apr 30, 2020

SELL
$74.34 - $121.82 $260,190 - $426,370
-3,500 Reduced 1.46%
235,740 $23.5 Million
Q4 2019

Jan 29, 2020

BUY
$114.37 - $129.46 $6.89 Million - $7.8 Million
60,263 Added 33.67%
239,240 $27.5 Million
Q3 2019

Oct 31, 2019

BUY
$117.16 - $138.52 $1.45 Million - $1.71 Million
12,360 Added 7.42%
178,977 $22.6 Million
Q2 2019

Jul 31, 2019

BUY
$81.74 - $120.34 $1.77 Million - $2.61 Million
21,690 Added 14.97%
166,617 $20.1 Million
Q1 2019

May 01, 2019

BUY
$83.25 - $102.12 $2.04 Million - $2.5 Million
24,500 Added 20.34%
144,927 $12.7 Million
Q4 2018

Jan 31, 2019

BUY
$90.66 - $116.63 $10.9 Million - $14 Million
120,427 New
120,427 $12 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $4.39B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Emerald Mutual Fund Advisers Trust Portfolio

Follow Emerald Mutual Fund Advisers Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Emerald Mutual Fund Advisers Trust, based on Form 13F filings with the SEC.

News

Stay updated on Emerald Mutual Fund Advisers Trust with notifications on news.